201 related articles for article (PubMed ID: 38250376)
21. Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.
Wang Z; Zhao Y; Jiang Y; Lv W; Wu L; Wang B; Lv L; Xu Q; Xin H
Sci Rep; 2015 Jul; 5():12651. PubMed ID: 26219474
[TBL] [Abstract][Full Text] [Related]
22. Translocator protein (TSPO) ligand-Ara-C (cytarabine) conjugates as a strategy to deliver antineoplastic drugs and to enhance drug clinical potential.
Denora N; Laquintana V; Trapani A; Lopedota A; Latrofa A; Gallo JM; Trapani G
Mol Pharm; 2010 Dec; 7(6):2255-69. PubMed ID: 20958082
[TBL] [Abstract][Full Text] [Related]
23. A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma.
Jimenez-Macias JL; Lee YC; Miller E; Finkelberg T; Zdioruk M; Berger G; Farquhar CE; Nowicki MO; Cho CF; Fedeles BI; Loas A; Pentelute BL; Lawler SE
J Control Release; 2022 Dec; 352():623-636. PubMed ID: 36349615
[TBL] [Abstract][Full Text] [Related]
24. Peptide-Drug Conjugate Targeting Keratin 1 Inhibits Triple-Negative Breast Cancer in Mice.
Ziaei E; Paiva IM; Yao SJ; Sarrami N; Mehinrad P; Lai J; Lavasanifar A; Kaur K
Mol Pharm; 2023 Jul; 20(7):3570-3577. PubMed ID: 37307328
[TBL] [Abstract][Full Text] [Related]
25. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R
Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360
[TBL] [Abstract][Full Text] [Related]
26. Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma.
Ramalho MJ; Loureiro JA; Coelho MAN; Pereira MC
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214012
[TBL] [Abstract][Full Text] [Related]
27. A dual-targeting peptide for glioblastoma screened by phage display peptide library biopanning combined with affinity-adaptability analysis.
Li X; Pu X; Wang X; Wang J; Liao X; Huang Z; Yin G
Int J Pharm; 2023 Sep; 644():123306. PubMed ID: 37572856
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.
Dragojevic S; Mackey R; Raucher D
Molecules; 2019 Sep; 24(18):. PubMed ID: 31489879
[TBL] [Abstract][Full Text] [Related]
29. Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.
Tortorella S; Karagiannis TC
J Membr Biol; 2014 Apr; 247(4):291-307. PubMed ID: 24573305
[TBL] [Abstract][Full Text] [Related]
30. Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model.
Zhao P; Anami Y; Gao P; Fan X; Li L; Tsuchikama K; Zhang N; An Z
MAbs; 2022; 14(1):2057269. PubMed ID: 35388745
[TBL] [Abstract][Full Text] [Related]
31. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and in vitro antitumor activity of a transferrin receptor-targeted peptide-doxorubicin conjugate.
Li S; Zhao H; Fan Y; Zhao G; Wang R; Wen F; Wang J; Wang X; Wang Y; Gao Y
Chem Biol Drug Des; 2020 Jan; 95(1):58-65. PubMed ID: 31452330
[TBL] [Abstract][Full Text] [Related]
33. Brain-targeted exosome-mimetic cell membrane nanovesicles with therapeutic oligonucleotides elicit anti-tumor effects in glioblastoma animal models.
Lee Y; Kim M; Ha J; Lee M
Bioeng Transl Med; 2023 Mar; 8(2):e10426. PubMed ID: 36925699
[TBL] [Abstract][Full Text] [Related]
34. A Multifunctional AIE Nanoprobe as a Drug Delivery Bioimaging and Cancer Treatment System.
Hu K; Zhou D; Rao L; Wang P; Xiang C; Chen F
Front Bioeng Biotechnol; 2021; 9():766470. PubMed ID: 34820365
[TBL] [Abstract][Full Text] [Related]
35. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
[TBL] [Abstract][Full Text] [Related]
36. Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells.
Ramalho MJ; Bravo M; Loureiro JA; Lima J; Pereira MC
Life Sci; 2022 May; 296():120435. PubMed ID: 35247437
[TBL] [Abstract][Full Text] [Related]
37. Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model.
Wu H; Liu Y; Chen L; Wang S; Liu C; Zhao H; Jin M; Chang S; Quan X; Cui M; Wan H; Gao Z; Huang W
Int J Nanomedicine; 2022; 17():6377-6398. PubMed ID: 36545220
[TBL] [Abstract][Full Text] [Related]
38. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
[TBL] [Abstract][Full Text] [Related]
39. Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma.
Liu X; Cao Z; Liu N; Gao G; Du M; Wang Y; Cheng B; Zhu M; Jia B; Pan L; Zhang W; Jiang Y; He W; Xu L; Zhang W; An Q; Guo Q; Gu J
Front Pharmacol; 2022; 13():975291. PubMed ID: 36059990
[TBL] [Abstract][Full Text] [Related]
40. Targeted Delivery of siRNA to Transferrin Receptor Overexpressing Tumor Cells via Peptide Modified Polyethylenimine.
Xie Y; Killinger B; Moszczynska A; Merkel OM
Molecules; 2016 Oct; 21(10):. PubMed ID: 27735873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
